Opendata, web and dolomites

FibroFix SIGNED

FibroFix™Cartilage, an innovative implant for cartilage repair and regeneration, introducing a new paradigm in osteoarthritis (OA) treatment.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 FibroFix project word cloud

Explore the words cloud of the FibroFix project. It provides you a very rough idea of what is the project "FibroFix" about.

25m    articular    ultimate    injuries    trade    quality    economic    deterioration    led    rubbing    osteoarthritic    burdens    pain    treatment    biomaterials    country    orthopaedic    13m    clinical    decreased    osteoarthritis    smooth    productivity    lesions    expensive    function    life    emulates    joint    recourse    total    heart    paradigm    prevention    frequent    tkr    effectiveness    stiffness    resurfacing    rehabilitation    shifting    half    public    severe    bones    characterised    resilient    oa    combination    investment    complications    grant    solutions    regeneration    minimum    11    regenerative    repair    cartilage    pressing    seeking    prevalence    potentially    prolonged    knee    fibrofix    drawbacks    finance    orthopaedics    times    disability    lubricious    orthox    innovative    replacement    chronic    hospitalizations    treatments    almost    additional    round    ratio    biocompatible    ing    disease    durable    health    lengthy    mobility    inefficient    solution    supports    involve    biostable    unmet    worldwide    postponement   

Project "FibroFix" data sheet

The following table provides information about the project.

Coordinator
ORTHOX LIMITED 

Organization address
address: 66 INNOVATION DRIVE MILTON PARK
city: ABINGDON
postcode: OX14 4RQ
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.orthox.co.uk/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2019-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ORTHOX LIMITED UK (ABINGDON) coordinator 50˙000.00

Map

 Project objective

Cartilage deterioration and injuries often lead to osteoarthritis (OA) – a long-term chronic disease resulting in bones rubbing together and creating pain, stiffness and severe disability. Knee cartilage injuries are very common and almost half of them go on to develop OA, which is second only to heart disease as a cause of work disability. Resulting from decreased quality of life, hospitalizations and loss of productivity, the economic cost of OA is particularly high in every country that it has been estimated. Currently, all treatments available, including Total Knee joint Replacement (TKR) as the ultimate recourse, are inefficient and expensive: they involve pain, lengthy rehabilitation, frequent complications and high costs. Therefore, given the increasing prevalence of knee OA, its associated burdens and the drawbacks of all available treatments, it is becoming increasingly important to develop an innovative cost-effective solution to this major public health problem worldwide.

FibroFix™ Cartilage is a well characterised, regenerative orthopaedic repair product to address the unmet and pressing clinical need of large and/or osteoarthritic articular cartilage lesions in the knee, developed by Orthox. It is biostable, biocompatible, emulates cartilage function and supports cartilage regeneration at the minimum cost effectiveness ratio. It allows resurfacing of large and/or potentially OA cartilage lesions, prolonged use of the joint, increased mobility, reduced pain and postponement or prevention of TKR. Smooth, robust, resilient, durable and lubricious, it is a unique combination to be applied in orthopaedics and biomaterials shifting the paradigm in knee OA treatment and up to 10 times less expensive than other solutions.

Over the previous 8 years, Orthox have led 11 major grant-funded programmes, raising more than €13M to finance product development. We are now seeking an additional €2.25M for the second investment round.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "FIBROFIX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "FIBROFIX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MealHero (2019)

Automated cooking for tasty and healthy meals in a convenient way

Read More  

SPANAR (2019)

Safe Perception And Navigation for Autonomous Robots

Read More  

MindTrack (2019)

Analysis of eye vergence responses for the early detection and monitoring of cognitive and mental disorders

Read More